What to Do If Nitrofurantoin Doesn’t Work for a UTI

When nitrofurantoin doesn’t clear your UTI, the single most important step is getting a urine culture with susceptibility testing so your doctor can identify exactly which bacterium is causing the infection and which antibiotic will kill it. Nitrofurantoin remains one of the most effective first-line drugs for simple bladder infections, but it can fail for reasons ranging from bacterial resistance to reduced kidney function to the infection being more complicated than initially assumed. What happens next depends on why it didn’t work, and figuring that out changes everything about your treatment.

Why Nitrofurantoin Sometimes Fails

Nitrofurantoin works by being concentrated in urine, where it damages bacterial DNA and proteins through multiple mechanisms at once. That multi-target approach is why resistance has historically been rare compared to other UTI antibiotics. But “rare” is not “nonexistent,” and resistance among the bacteria that cause UTIs has been climbing over the past two decades worldwide.¹ When resistance does occur, it typically involves changes in the bacterial enzymes that normally activate the drug inside the cell. Without those enzymes working properly, nitrofurantoin never converts to the toxic compounds that kill the bacteria.²

Resistance isn’t the only reason for failure, though. Nitrofurantoin only works against bacteria in the bladder because it concentrates in urine. If the infection has spread to the kidneys or beyond, the drug doesn’t reach adequate levels in those tissues. It also has limited activity against certain organisms like Pseudomonas and Proteus species that sometimes cause UTIs. And as we’ll see below, your kidney function plays a direct role in whether the drug can even reach effective concentrations in your urine.

Getting a Urine Culture Is the Critical First Step

When your doctor prescribed nitrofurantoin the first time around, there’s a good chance they did so empirically, meaning they chose the drug based on what typically works for uncomplicated UTIs rather than testing which bug you actually had. That’s standard practice for a first episode of simple cystitis. But once treatment fails, guessing again is a bad strategy. A urine culture identifies the specific bacterium and tests which antibiotics can kill it.

One practical point that matters here: if you’ve already started a different antibiotic before providing the culture sample, the results become much less reliable. Research shows that cultures taken after even a single dose of antibiotics are far less likely to grow the offending organism. In one study, pre-antibiotic cultures were positive in 99% of cases, but after one antibiotic dose, that dropped to about 35%, and the cultures missed the majority of resistant organisms.³ If possible, provide a urine sample before starting any new antibiotic.

There’s also a subtler diagnostic question worth understanding. With nitrofurantoin resistance still relatively low across most common UTI-causing bacteria, simply confirming which organism you’re dealing with can be more useful than the susceptibility results themselves.⁴ If the culture grows something nitrofurantoin doesn’t cover well, like Proteus or Pseudomonas, that alone explains the failure without needing to invoke resistance.

Alternative Antibiotics Your Doctor May Consider

The specific antibiotic your doctor switches to depends on your culture results, your medical history, and whether the infection is confined to the bladder. For uncomplicated cystitis in otherwise healthy adults, the main alternatives include trimethoprim-sulfamethoxazole and fosfomycin. Both are considered first-line options for simple bladder infections, and either may be effective against organisms that resist nitrofurantoin. In one clinical trial comparing nitrofurantoin head-to-head with trimethoprim-sulfamethoxazole for uncomplicated cystitis, clinical cure rates were similar, around 84% and 79% respectively.

Fosfomycin has a practical advantage in that it’s given as a single dose, which some patients prefer. Its effectiveness can be somewhat lower than a full course of other antibiotics, but it covers many resistant organisms. For infections caused by bacteria that produce extended-spectrum beta-lactamases (ESBLs), a growing concern in UTI treatment worldwide, nitrofurantoin and trimethoprim-sulfamethoxazole are still considered preferred agents when susceptibility is confirmed, because these oral drugs can avoid the need for intravenous antibiotics.

Fluoroquinolones like ciprofloxacin are effective against many UTI-causing bacteria, but they come with important caveats. The FDA removed uncomplicated UTI as an indication for oral fluoroquinolones in 2016 because the risk of serious side effects, including tendon damage and nerve problems, was considered disproportionate for such a common, usually self-limiting condition.⁵ Fluoroquinolones are still used for complicated UTIs or kidney infections where fewer alternatives exist, but for a simple bladder infection they’re typically reserved for situations where nothing safer will work.

When Kidney Function Is Part of the Problem

Nitrofurantoin is unusual among antibiotics in that it works almost entirely through concentration in urine rather than through blood levels. This means your kidneys play a starring role: if they aren’t filtering well enough, nitrofurantoin may not reach therapeutic concentrations in the bladder. For years, guidelines advised against using nitrofurantoin in anyone with an estimated glomerular filtration rate (eGFR) below 30 or even 45 mL/min, based on the logic that reduced kidney function would produce subtherapeutic urine levels.

The evidence on this is more nuanced than the old blanket prohibition suggested. A large study of older women found that nitrofurantoin did have higher failure rates compared to alternatives like ciprofloxacin in women with reduced kidney function, with roughly twice the odds of needing a second antibiotic or a hospital visit.⁶ Interestingly, though, that same study found that nitrofurantoin’s failure rate was also elevated in women with relatively normal kidney function, suggesting that reduced filtration alone doesn’t fully explain the pattern.

A separate large study quantified the effect differently. For every 10 mL/min decrease in eGFR, the odds of nitrofurantoin failing rose by about 5%. Among women with uncomplicated cystitis and eGFR below 60, fosfomycin had a meaningfully lower failure rate, around 16%, compared to roughly 23% for nitrofurantoin.⁷ If your nitrofurantoin failed and your kidney function is reduced, your doctor may specifically choose fosfomycin or another alternative that doesn’t depend so heavily on renal concentration.

This doesn’t mean nitrofurantoin should never be used in people with lower kidney function. Current thinking generally allows it for short courses down to an eGFR of about 30 mL/min, though the risk of failure is higher, and alternatives deserve stronger consideration. If you’re an older adult or have chronic kidney disease, this is worth discussing explicitly with your doctor when a UTI doesn’t respond to first-line treatment.

Signs the Infection May Be More Than Simple Cystitis

Nitrofurantoin is designed for uncomplicated bladder infections. If your infection has traveled to the kidneys (pyelonephritis) or involves complicating factors, nitrofurantoin was likely the wrong tool from the start, and that can look like “failure” when really the issue was scope. Symptoms that suggest the infection has gone beyond the bladder include fever, flank pain, nausea, and chills. These warrant prompt medical attention and often require antibiotics that reach adequate tissue levels, not just urine concentrations.

Structural abnormalities in the urinary tract can also set the stage for treatment failure. Kidney stones, bladder stones, or anatomical differences that prevent complete bladder emptying can create environments where bacteria persist despite antibiotics. Bladder stones, for example, can result from chronic infection and simultaneously harbor bacteria that reinfect the surrounding tissue.⁸ If your UTI keeps coming back despite appropriate antibiotics, your doctor may order imaging to check for structural issues that need to be addressed alongside the infection itself.

Other complicating factors include diabetes, immunosuppression, catheter use, and urinary retention. These conditions change the treatment calculus because they increase the risk of the infection being deeper, harder to clear, or caused by more unusual organisms. In these settings, culture-guided therapy becomes even more essential, and nitrofurantoin may be insufficient regardless of susceptibility.

UTIs During Pregnancy

Pregnancy adds a specific layer of complexity to UTI treatment. The American College of Obstetricians and Gynecologists lists nitrofurantoin as an option for treating UTIs in pregnant individuals, but with an important timing caveat: there are some data suggesting possible associations between first-trimester use and congenital anomalies, though the evidence is mixed and has methodological limitations. When no appropriate alternatives are available, nitrofurantoin is considered reasonable in the first trimester, and it can be used as first-line treatment in the second and third trimesters.⁹

If nitrofurantoin fails during pregnancy, the antibiotic choices are more constrained than in non-pregnant adults. Beta-lactams like amoxicillin-clavulanate or cephalosporins are commonly used alternatives. Fluoroquinolones are generally avoided in pregnancy. Fosfomycin is another option. Culture results are especially important here because untreated or undertreated UTIs during pregnancy carry real risks, including preterm labor and kidney infection, so getting the right antibiotic quickly matters more than in a typical non-pregnant patient.

One additional concern worth knowing about: nitrofurantoin should be avoided in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a genetic condition affecting red blood cells. In those patients, the drug can trigger hemolytic anemia, where red blood cells break down faster than the body can replace them.⁹ If you have G6PD deficiency and were prescribed nitrofurantoin, that could explain both the failure and additional symptoms.

Why Some UTIs Keep Coming Back Despite Antibiotics

If your nitrofurantoin failure is part of a pattern of recurring UTIs, the problem may not be resistance in the usual sense. Bacteria that cause UTIs, particularly E. coli, have a remarkable ability to invade the cells lining the bladder and set up shop inside them. Once inside those cells, they multiply rapidly and form tight-knit communities that are shielded from antibiotics circulating in the urine.¹⁰ Some of these intracellular bacteria enter a dormant state, essentially going quiet enough to evade both the immune system and antibiotic treatment, then reactivating later to trigger a new infection.¹¹

This phenomenon is distinct from antibiotic resistance. A resistant bacterium has genetic changes that allow it to survive in the presence of a drug. A persistent bacterium, by contrast, simply hides where the drug can’t reach it in sufficient concentration. Standard susceptibility testing may show the organism is fully sensitive to nitrofurantoin, yet the infection recurs because some bacteria were tucked away inside bladder cells or within biofilms during treatment.

Biofilms add another dimension to this problem. When bacteria form biofilms on the bladder wall or on urinary devices like catheters, they produce a protective matrix that dramatically increases their tolerance to antibiotics. Studies have found that bacteria within biofilms can tolerate antibiotic concentrations far exceeding what can realistically be achieved in urine.¹² This is one reason why recurrent UTIs are so frustrating. The standard approach of a short antibiotic course may clear the planktonic (free-floating) bacteria in the urine while leaving the biofilm community intact and ready to seed the next episode.

Preventing Recurrence After Treatment Failure

Once you’ve resolved the immediate infection, the conversation often shifts to prevention, especially if you’ve already had multiple UTIs. Low-dose antibiotic prophylaxis, where you take a small dose of an antibiotic daily or after triggers like sexual intercourse, has been the traditional approach for recurrent UTIs. But given growing resistance concerns and the side effects of prolonged antibiotic use, non-antibiotic options have gained attention.

Methenamine hippurate is one option that has seen a resurgence of interest. It works differently from conventional antibiotics: in acidic urine, it breaks down into formaldehyde, which acts as a broad antimicrobial agent. A systematic review found that methenamine was effective at extending the time between UTI episodes and reducing the overall number of recurrences, performing on par with antibiotic prophylaxis.¹³ Because it doesn’t work through the same mechanism as conventional antibiotics, it doesn’t drive resistance in the same way, which makes it an appealing long-term strategy.

Other preventive approaches include vaginal estrogen for postmenopausal women, cranberry products (which have modest evidence for certain populations), and behavioral modifications like adequate hydration and post-intercourse voiding. None of these are guaranteed to prevent recurrence, but they reduce the frequency of episodes for many people. If your UTI pattern includes multiple nitrofurantoin failures, prevention becomes at least as important as treating each individual episode, because each round of antibiotics carries its own costs in terms of side effects and resistance selection.

When Home Treatment Isn’t Enough

In a small number of cases, a UTI that doesn’t respond to oral antibiotics requires intravenous treatment. This is most common with multidrug-resistant organisms, kidney infections that aren’t improving, or patients with complicating conditions that make oral treatment unreliable. Traditionally, intravenous antibiotics meant a hospital stay, but outpatient parenteral antibiotic therapy (OPAT) programs increasingly allow patients to receive IV drugs at home while being monitored by a medical team.¹⁴ If your infection involves a resistant organism and none of the oral alternatives are suitable, this kind of arrangement is worth discussing with your provider. It’s not a common outcome for straightforward UTIs, but it exists as an option for the genuinely difficult cases where everything oral has either failed or is inappropriate.